Home/Filings/4/0001209191-23-045889
4//SEC Filing

Camerlinck Robert 4

Accession 0001209191-23-045889

CIK 0001800682other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 5:05 PM ET

Size

5.4 KB

Accession

0001209191-23-045889

Insider Transaction Report

Form 4
Period: 2023-08-11
Camerlinck Robert
Chief Operating Officer
Transactions
  • Sale

    Class A Common Stock

    2023-08-11$0.77/sh30,646$23,45326,958,642 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs").
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.74 to $0.79. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Cano Health, Inc.

CIK 0001800682

Entity typeother

Related Parties

1
  • filerCIK 0001942114

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 5:05 PM ET
Size
5.4 KB